Sleep Apnea May Amplify GLP-1 Survival Benefits in Type 2 Diabetes
A study of nearly 1.8 million adults with diabetes suggests patients with obstructive sleep apnea derive a 20% greater mortality reduction from GLP-1 therapy than those without the sleep disorder.
